论文信息 - Recyclization of 1-aryl-4-iminoimidazolidin-2-ones on treatment with hydrazine: Synthesis of 5-arylaminomethyl-2,4-dihydro[1,2,4]triazol-3-ones - 字舞流文

Recyclization of 1-aryl-4-iminoimidazolidin-2-ones on treatment with hydrazine: Synthesis of 5-arylaminomethyl-2,4-dihydro[1,2,4]triazol-3-ones

M. Krayushkin | B. Lichitsky | A. Komogortsev | A. A. Dudinov | P. P. Purygin | K. S. Krylov

[1] R. Morimoto,et al. Arylazanylpyrazolone derivatives as inhibitors of mutant superoxide dismutase 1 dependent protein aggregation for the treatment of amyotrophic lateral sclerosis. , 2013, Journal of medicinal chemistry.

[2] T. Torroba,et al. A diastereoselective synthesis of pseudopeptidic hydantoins by an Ugi/cyclization/Ugi sequence , 2012 .

[3] G. B. Brown,et al. Effects of log P and phenyl ring conformation on the binding of 5-phenylhydantoins to the voltage-dependent sodium channel. , 1997, Journal of Medicinal Chemistry.

[4] C. Strader,et al. 2(S)-((3,5-bis(trifluoromethyl)benzyl)-oxy)-3(S)-phenyl-4- ((3-oxo-1,2,4-triazol-5-yl)methyl)morpholine (1): a potent, orally active, morpholine-based human neurokinin-1 receptor antagonist. , 1996, Journal of medicinal chemistry.

[5] A. Markovac,et al. Hydantoins as antitumor agents. , 1977, Journal of medicinal chemistry.

[6] V. N. Artemov,et al. Reactions forming and recyclizing heterocycles , 1970 .